†rsrapport Nycomed - Takeda Pharmaceuticals International GmbH

ACCOUNTSPARENT COMPANY ACCOUNTS NOTES4. Investments in subsidiaries2000 1998/99(000)DKK(000)DKK7 monthsCosts beginning of year 1,348,884 0Additions in the year 1,464 1,348,884Retirements in the year 0 0Costs 31. December 1,350,348 1,348,884Value adjustments beginning of year - 22,802 0Adjustment of goodwill - 30,279 0Foreign currency conversion effect - 27,856 - 1,295Result before tax 5,032 - 19,068Income tax expenses 14,268 - 2,439Dividend for the year 0 0Value adjustment 31. December - 61,637 - 22,802Book value 31. December 1,288,711 1,326,082Company Domicile Share of equityNycomed Danmark A/S Roskilde, Denmark 100 %5. Receivables from affiliated entitiesNycomed Danmark A/S, Danmark 8,542 13,979Nycomed Pharma AS, Norge 0 64,901Total 8,542 78,8806. Other receivablesReceivable from Nycomed Amersham plc. inconnection with adjustment of purchase pricefor shares in Nycomed Danmark A/S 8,636 46,555–58–